Role of technology assessment in health benefits coverage for medical devices

American Journal of Managed Care

Volumn 4, Issue SPEC. ISS. SEPT., 1998, Pages

  Braslow, Nelson M ^a   Shatin, Deborah ^b   McCarthy, Douglas B ^b   Newcomer, Lee N ^a  

^a UNITED HEALTHCARE   (United States)

^b UNITEDHEALTH GROUP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; DECISION MAKING; DEVICE; HEALTH CARE PLANNING; MANAGED CARE; MEDICAL INSTRUMENTATION; POLICY; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS;

COST-BENEFIT ANALYSIS; DECISION MAKING, ORGANIZATIONAL; EQUIPMENT AND SUPPLIES; EVIDENCE-BASED MEDICINE; INSURANCE COVERAGE; MANAGED CARE PROGRAMS; PUBLIC POLICY; SOCIAL RESPONSIBILITY; TECHNOLOGY ASSESSMENT, BIOMEDICAL; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 7844223257     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. 1996 Medical Healthcare Marketplace Guide. New York, NY: IDD Enterprises; 1997.
2. Medical Device Industry Fact Book. 3rd ed. Santa Monica, CA: Canon Publications, Inc.; 1996.
3. Weisbrod BA. The health care quadrilemma: An essay on technological change, insurance, quality of care, and cost containment. J Econ Lit 1991;29:523-552.
4. Starr P. The Social Transformation of American Medicine. New York: Basic Books; 1982:379-419.
5. Wennberg JE, Gittelsohn A. Small area variations in health care delivery. Science 1973;182:1102-1108.
6. Chassin MR, Kosecoff J, Park RE, et al. Does inappropriate use explain geographic variations in the use of health care services? A study of three procedures. JAMA 1987; 258:2533-2537.
7. Wennberg JE, Barnes BA, Zubkoff M. Professional uncertainty and the problem of supplier-induced demand. Soc Sci Med 1982;16:811-824.
8. Manning WG, Newhouse JP, Duan N, et al. Health insurance and the demand for medical care: Evidence from a randomized experiment. Am Econ Rev 1987;77:251-277.
9. Lawthers AG, Localio AR, Laird NM, et al. Physicians' perceptions of the risk of being sued. J Health Polit Policy Law 1992;17:463-482.
10. Rettig RA. Medical innovation duels cost containment. Health Aff 1994;13(3):7-27.
11. Schwartz WB. In the pipeline: A wave of valuable technology. Health Aff 1994;13:(3)70-79.
12. Gelijns A, Rosenberg N. The dynamics of technological change in medicine. Health Aff 1994;13(3):28-46.
13. Fronstin P, Goldberg LG, Robins PK. An analysis of the decline in private health insurance coverage between 1988 and 1992. Soc Sci Q 1997;78:44-66.
14. Hamilton DR. Economic Implications of Rising Health Care Costs. Washington, DC: Congress of the US, Congressional Budget Office; 1992.
15. Jensen GA, Morrisey MA, Gaffney S, Liston DK. The new dominance of managed care: Insurance trends in the 1990s. Health Aff 1997;16(1):125-136.
16. Institute of Medicine. Assessing Medical Technologies. Washington, DC: National Academy Press; 1985:2.
17. Rettig RA. Health Care in Transition: Technology Assessment in the Private Sector. Santa Monica, CA: RAND; 1997.
18. Office of Technology Assessment. Report on Assessing Efficacy and Safety of Medical Technologies. Washington, DC: Congress of the US, Office of Technology Assessment; 1978.
19. Institute of Medicine. Assessing Medical Technologies. Washington, DC: National Academy of Sciences; 1985.
20. Foote SB. Managing the Medical Arms Race: Public Policy and Medical Device Innovation. Berkeley, CA: University of California Press; 1992:165-170.
21. Positron emission tomography, part 1: Myocardial perfusion imaging for the evaluation of ischemic health disease. ECRI. Plymouth Meeting, PA: January 1995; 3.
22. Positron emission tomography, part 2: Myocardial viability imaging for the evaluation of ischemic heart disease. ECRI. Plymouth Meeting, PA: February 1995; 3.
23. Positron emission tomography for the evaluation of ischemic heart disease, part 3: Regulatory and reimbursement update. ECRI. Plymouth Meeting, PA: May 1995; 3.
24. Brook RH, Lohr KN. Efficacy, effectiveness, variations, and quality: Boundary crossing research. Med Care 1985; 23:710-722.
25. Eddy DM. Clinical decision making: From theory to practice. Benefit language: Criteria that will improve quality while reducing costs. JAMA 1996;275:650-657.
26. Hunink M. Cost effectiveness analysis for medical technologies and pharmaceuticals. Lecture presentation at: Harvard School of Public Health; June 10, 1998; Cambridge, MA.
27. Schrag D, Kuntz KM, Garber JE, Weeks JC. Decision analysis - effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med 1997;336:1465-1471.
28. Burke W, Daly M, Garber J, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer, II: BRCA1 and BRCA2. JAMA 1997;277:997-1003.
29. Greene MH. Genetics of breast cancer. Mayo Clin Proc 1997;72:54-65.
30. Schwartz LM, Woloshin S, Black WC, Welch HG. The role of numeracy in understanding the benefit of screening mammography. Ann Intern Med 1997;127:966-972.
31. Steiner CA, Powe NR, Anderson GF, Das A. Technology coverage decisions by health care plans and considerations by medical directors. Med Care 1997;35:472-489.
32. Ramsey SD, Pauly MV. Structural incentives and adoption of medical technologies in HMO and fee-for-service health insurance plans. Inquiry 1997;34:228-236.
33. Chernew M, Fendrick MA, Hirth RA. Managed care and medical technology: Implications for cost growth. Health Aff 1997;16(2):196-206.
34. Durenberger DF, Foote SB. Technology and health reform: A legislative perspective. Health Aff 1994;13(3):197-205.
35. The President's Advisory Commission on Consumer Protection and Quality in the Health Care Industry. Quality First: Better Health Care for All Americans. Final Report to the President of the United States Washington, DC: US Government Printing Office; March 1998.
36. Jensen GA, Gabel JR. State mandated benefits and a firm's decision to offer insurance. J Reg Econ 1992;4:379-404.
37. Garber AM. Can technology assessment control health spending? Health Aff 1994;13(3):115-126.